ATE466280T1 - Versuchsanordnung zum nachweis von bindungspartnern - Google Patents

Versuchsanordnung zum nachweis von bindungspartnern

Info

Publication number
ATE466280T1
ATE466280T1 AT99966795T AT99966795T ATE466280T1 AT E466280 T1 ATE466280 T1 AT E466280T1 AT 99966795 T AT99966795 T AT 99966795T AT 99966795 T AT99966795 T AT 99966795T AT E466280 T1 ATE466280 T1 AT E466280T1
Authority
AT
Austria
Prior art keywords
binding partners
detecting binding
experimental arrangement
leukemia
sample
Prior art date
Application number
AT99966795T
Other languages
English (en)
Inventor
Richard Ian Christopherson
Remedios Cristobal G Dos
Original Assignee
Medsaic Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP7916A external-priority patent/AUPP791698A0/en
Priority claimed from AUPQ0425A external-priority patent/AUPQ042599A0/en
Application filed by Medsaic Pty Ltd filed Critical Medsaic Pty Ltd
Application granted granted Critical
Publication of ATE466280T1 publication Critical patent/ATE466280T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Basic Packing Technique (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99966795T 1998-12-23 1999-12-23 Versuchsanordnung zum nachweis von bindungspartnern ATE466280T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP7916A AUPP791698A0 (en) 1998-12-23 1998-12-23 An assay
AUPQ0425A AUPQ042599A0 (en) 1999-05-18 1999-05-18 An assay-ii
PCT/AU1999/001156 WO2000039580A1 (en) 1998-12-23 1999-12-23 An assay to detect a binding partner

Publications (1)

Publication Number Publication Date
ATE466280T1 true ATE466280T1 (de) 2010-05-15

Family

ID=25645962

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99966795T ATE466280T1 (de) 1998-12-23 1999-12-23 Versuchsanordnung zum nachweis von bindungspartnern

Country Status (14)

Country Link
US (1) US7560226B2 (de)
EP (1) EP1151300B1 (de)
JP (1) JP4763135B2 (de)
KR (1) KR100795757B1 (de)
CN (1) CN1231761C (de)
AT (1) ATE466280T1 (de)
BR (1) BR9916449A (de)
CA (1) CA2356286C (de)
DE (1) DE69942314D1 (de)
DK (1) DK1151300T3 (de)
ES (1) ES2344180T3 (de)
NZ (1) NZ525421A (de)
PT (1) PT1151300E (de)
WO (1) WO2000039580A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU740830B2 (en) * 1998-01-29 2001-11-15 Glaucus Proteomics B.V. High density arrays for proteome analysis and methods and compositions therefor
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
TWI314212B (en) 2000-12-14 2009-09-01 Stroobant Paul Differential phage capture proteomics
EP1248108B1 (de) * 2001-03-29 2011-08-31 Canon Kabushiki Kaisha Verfahren zum Zellscreening und dafür geeignete Substrata
JP4594588B2 (ja) 2001-04-10 2010-12-08 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニヴァーシティ 抗体特異的プロファイルの治療的および診断的使用方法
WO2003058193A2 (en) * 2001-07-02 2003-07-17 The Board Of Trustees Of The Leland Stanford Junior University Microarrays for cell phenotyping and manipulation
ATE443259T1 (de) 2001-09-20 2009-10-15 Univ Texas Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper- komplexe mit elisa-tests
WO2003075016A1 (en) 2002-03-07 2003-09-12 Cambridge University Technical Services Limited (Cuts) Scd fingerprints
CA2490522A1 (en) * 2002-06-20 2003-12-31 Paul Stroobant Improved methods for performing differential capture proteomics
DE10236101A1 (de) * 2002-08-05 2004-02-26 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Verfahren und Kit zur Durchführung funktioneller Tests an biologischen Zellen
AU2004243690A1 (en) * 2003-03-03 2004-12-09 Burstein Technologies, Inc. Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
US20040235027A1 (en) * 2003-03-31 2004-11-25 Regent Of The University Of California Preparation and application of ligand-biopolymer conjugates
SE0301058D0 (sv) 2003-04-10 2003-04-10 Biacore Ab Method and kit for cell analyte assay
WO2004088318A1 (en) * 2003-04-04 2004-10-14 Biacore Ab Method and kit for cell analyte assay
US8546082B2 (en) * 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20080138808A1 (en) * 2003-09-11 2008-06-12 Hall Thomas A Methods for identification of sepsis-causing bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8288523B2 (en) 2003-09-11 2012-10-16 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US20050069958A1 (en) * 2003-09-26 2005-03-31 Mills Rhonda A. Method for simultaneous evaluation of a sample containing a cellular target and a soluble analyte
DE102004039628A1 (de) * 2004-08-10 2006-02-23 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Trägerplatte zur Durchführung funktioneller Tests an biologischen Zellen sowie Verfahren zur Beschichtung der Trägerplatte
EP1888784A2 (de) * 2005-05-18 2008-02-20 Wyeth a Corporation of the State of Delaware Leukämiekrankheitsgene und verwendungen davon
CA2610875A1 (en) * 2005-06-06 2006-12-14 Decision Biomarkers, Inc. Assays based on liquid flow over arrays
US20070042443A1 (en) 2005-08-17 2007-02-22 Quest Diagnostics Investments Incorporated Hematopoietic cell phenotyping using free circulating cellular markers
US7955837B2 (en) * 2005-10-29 2011-06-07 Bayer Technology Services Gmbh Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof
US20070105165A1 (en) * 2005-11-04 2007-05-10 Charles Goolsby Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers
US8623356B2 (en) 2005-11-29 2014-01-07 The University Of Sydney Demibodies: dimerization-activated therapeutic agents
WO2007087370A2 (en) * 2006-01-25 2007-08-02 Caprion Pharmaceuticals, Inc. Tat-038 and methods of assessing and treating cancer
US8768629B2 (en) * 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
CN103424541B (zh) 2006-05-18 2018-01-30 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
WO2009108932A2 (en) * 2008-02-28 2009-09-03 The Johns Hopkins University Selectin ligands useful in the diagnosis and treatment of cancer
GB0818614D0 (en) * 2008-10-10 2008-11-19 Univ Dublin City Platelet Analysis
WO2010045318A2 (en) * 2008-10-14 2010-04-22 Caris Mpi, Inc. Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
CN107254538A (zh) 2008-11-12 2017-10-17 卡里斯生命科学瑞士控股有限责任公司 使用外来体来确定表现型的方法和系统
KR20130056855A (ko) 2010-03-01 2013-05-30 카리스 라이프 사이언스 룩셈부르크 홀딩스 치료진단용 생물학적 지표들
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
AU2011316477A1 (en) * 2010-10-11 2013-05-02 Medsaic Pty Ltd Assay for disease detection
ES2578160T3 (es) 2011-08-12 2016-07-21 Lsi Medience Corporation Procedimiento de diagnóstico de infecciones de sitio quirúrgico
CN103235124A (zh) * 2013-04-22 2013-08-07 复旦大学 一种基于硝酸纤维素膜的便捷癌细胞捕获芯片
CN105473745B (zh) * 2013-06-21 2019-12-03 约翰霍普金斯大学 用于表征人膜蛋白的功能和相互作用的病毒体展示阵列
JP2018502281A (ja) * 2014-11-20 2018-01-25 ジーイー・ヘルスケア・ユーケイ・リミテッド 固体支持体材料に固定された認知症及びアルツハイマー病関連バイオマーカーの検出
CN105005484B (zh) * 2015-08-12 2021-04-20 厦门雅基软件有限公司 一种跨平台游戏开发工具的事件分发方法
EP3651761A4 (de) * 2017-07-08 2021-04-28 The General Hospital Corporation Screening-plattform zur identifizierung therapeutischer arzneimittel oder mittel zur behandlung von morbus alzheimer
CN119798359A (zh) * 2025-01-06 2025-04-11 兰州大学 一种基于巯基-烯烃光点击化学的环肽构建方法及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS589070A (ja) * 1981-04-29 1983-01-19 チバ−ガイギ−・アクチエンゲゼルシヤフト 免疫分析用装置及びキツト
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
US4797356A (en) * 1985-12-02 1989-01-10 Konishiroku Photo Industries, Co., Ltd Monoclonal antibodies specific to glactosyltransferase isoenzyme II and their use in cancer immunoassays
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5217869A (en) * 1987-10-13 1993-06-08 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
GB8810400D0 (en) * 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5059522A (en) * 1988-08-18 1991-10-22 Wayne Lawrence G Intrinsic enzyme dot blot immunoassay or indentification of microorganisms
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5532135A (en) * 1990-02-02 1996-07-02 Cancer Research Fund Of Contra Costa Solid-phase competitive assay utilizing a fusion protein
US5726064A (en) * 1990-11-22 1998-03-10 Applied Research Systems Ars Holding Nv Method of assay having calibration within the assay
US5234816A (en) * 1991-07-12 1993-08-10 Becton, Dickinson And Company Method for the classification and monitoring of leukemias
US5597735A (en) * 1992-05-11 1997-01-28 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Health And Welfare Glycolipids for serodiagnosis of tuberculosis and leprosy
JPH07508179A (ja) * 1992-08-21 1995-09-14 シェリング・コーポレーション ヒトインターロイキン−１３
ES2051651B1 (es) * 1992-12-10 1995-01-01 Univ Salamanca Procedimiento para la cuantificacion simultanea, en una sola medicion, de los principales tipos de linfocitos humanos y sus subpoblaciones.
DE69426948T2 (de) * 1993-02-09 2001-10-11 Becton Dickinson And Co., Franklin Lakes Automatische Bestimmung der Zellinie schwerer Leukämien durch Flusszytometrie
WO1995005604A2 (en) * 1993-08-13 1995-02-23 Molecular Geriatrics Corporation Methods for the diagnosis of alzheimer's disease
US5692220A (en) * 1993-09-02 1997-11-25 Coulter Corporation Decision support system and method for diagnosis consultation in laboratory hematopathology
CA2173592C (en) * 1993-10-06 2007-09-25 Michael J. P. Lawman Stem cell proliferation factor
US5861158A (en) * 1993-11-17 1999-01-19 The United States Of America As Represented By The Deptartment Of Health And Human Services Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor
JP3533541B2 (ja) * 1995-01-25 2004-05-31 旭メディカル株式会社 細胞選択フィルター
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6265150B1 (en) * 1995-06-07 2001-07-24 Becton Dickinson & Company Phage antibodies
US5968513A (en) 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
WO1998008083A1 (en) * 1996-08-20 1998-02-26 Motorola Inc. Method and apparatus for detecting predetermined molecular structures in a sample
US6087102A (en) 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US7794946B1 (en) 1998-02-04 2010-09-14 Life Technologies Corporation Microarray and uses therefor

Also Published As

Publication number Publication date
KR20010093221A (ko) 2001-10-27
CN1334922A (zh) 2002-02-06
CA2356286A1 (en) 2000-07-06
US7560226B2 (en) 2009-07-14
JP2002533723A (ja) 2002-10-08
EP1151300B1 (de) 2010-04-28
WO2000039580A1 (en) 2000-07-06
EP1151300A4 (de) 2002-07-31
DE69942314D1 (de) 2010-06-10
DK1151300T3 (da) 2010-07-12
JP4763135B2 (ja) 2011-08-31
PT1151300E (pt) 2010-06-21
KR100795757B1 (ko) 2008-01-21
ES2344180T3 (es) 2010-08-19
HK1041922A1 (en) 2002-07-26
US20020019018A1 (en) 2002-02-14
CN1231761C (zh) 2005-12-14
EP1151300A1 (de) 2001-11-07
NZ525421A (en) 2004-10-29
BR9916449A (pt) 2002-01-22
CA2356286C (en) 2010-12-21

Similar Documents

Publication Publication Date Title
ATE466280T1 (de) Versuchsanordnung zum nachweis von bindungspartnern
TR200000565T2 (tr) Biyolojik örneklerdeki analiz bileşenlerinin hızlı analizi için yöntem
ATE290205T1 (de) Vorrichtung und verfahren zum nachweis und identifizieren von infektiösen wirkstoffen
DE69530861D1 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver immunoassays
ATE254285T1 (de) Geräte und verfahren, die strukturfelder zum binden von analyten verwenden
DE68904370D1 (de) Vorrichtung fuer biologische analysen mittels enzymimmun-test von antikoerpern oder antigenen in einem serum.
DE59814441D1 (de) Verwendung von kontrollflächen zur detektion von störproben in einem nachweisverfahren
ATE228247T1 (de) Testreagentien und testvorrichtungen
TR200001765T2 (tr) Duyguları ayırt etmek için aletler ve yöntemler.
ATE397752T1 (de) Verfahren und verwendung von anordungen von proteinfixierungsmitteln
TR199902473T2 (xx) Gen s�ralay�c� ve y�ntemler.
ATE118275T1 (de) Immunoassayverfahren zum nachweis von antigenen.
TR200001313T2 (tr) Protein etkileşimlerini ve fonksiyonel ilişkileri kaydeden tarama sistemleri
ATE133257T1 (de) Ermittlung und quantifizierung mehrerer analyten unter verwendung von markierungstechniken
DE69928507D1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
ES2144604T3 (es) Inmunosubstraccion electroforetica capilar para clasificar y determinar las proteinas m.
DE69732034D1 (de) Assay-verfahren
DE68919387D1 (de) DNS- und RNS-Proben, Methoden und Testsätze zum Nachweis von Salmonella.
DE69922225D1 (de) Cobalamintest
DE69617568D1 (de) Immunoassay Vorrichtung und Testverfahren zu seiner Verwendung
CA2361700A1 (en) METHOD FOR DETECTING ANALYTES IN A SAMPLE FOR TEST AND MEASUREMENT MEDIUM RELATING THERETO
ATE215095T1 (de) Immunologisches testverfahren zur quantifizierung von peg-modifiziertem humanem granulozyten- kolonie-stimulierender-faktor
DK72082A (da) Cytoreceptor-proeve
ATE157773T1 (de) Immonoassay
ATE312203T1 (de) Dynamische bestimmung von analyten durch arrays auf inneren oberflächen